Novartis (NVS)

Add to Watchlists Create an Alert
88.42 -0.71  -0.80% NYSE Jul 25, 1:40PM BATS Real time Currency in USD

Novartis Cash from Investing (TTM):

465.00M for June 30, 2014

View 4,000+ financial data types

View Full Chart

Novartis Cash from Investing (TTM) Chart

Export Data
Save Image

Novartis Historical Cash from Investing (TTM) Data

View and export this data going back to 2000. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 465.00M
March 31, 2014 -1.225B
Dec. 31, 2013 -3.352B
Sept. 30, 2013 -3.233B
June 30, 2013 -3.31B
March 31, 2013 -4.534B
Dec. 31, 2012 -5.675B
Sept. 30, 2012 -3.963B
June 30, 2012 -3.497B
March 31, 2012 -1.728B
Dec. 31, 2011 -792.00M
Sept. 30, 2011 -555.00M
June 30, 2011 -9.021B
March 31, 2011 -14.13B
Dec. 31, 2010 -15.76B
Sept. 30, 2010 -19.36B
June 30, 2010 -11.45B
March 31, 2010 -12.51B
Dec. 31, 2009 -14.22B
Sept. 30, 2009 -11.76B
June 30, 2009 -26.70B
March 31, 2009 -16.64B
   
Dec. 31, 2008 -10.37B
Sept. 30, 2008 -10.32B
June 30, 2008 4.817B
March 31, 2008 -1.643B
Dec. 31, 2007 -6.244B
Sept. 30, 2007 -5.157B
June 30, 2007 -3.702B
March 31, 2007 -7.076B
Dec. 31, 2006 -6.357B
Sept. 30, 2006 -6.754B
June 30, 2006 -12.52B
March 31, 2006 -10.02B
Dec. 31, 2005 -7.168B
Sept. 30, 2005 -5.527B
June 30, 2005 -60.00M
March 31, 2005 876.00M
Dec. 31, 2004 -2.816B
Sept. 30, 2004 -3.734B
June 30, 2004 -4.339B
March 31, 2004 -2.468B
Dec. 31, 2003 -1.231B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

NVS Cash from Investing (TTM) Benchmarks

Companies
Roche Holding
GlaxoSmithKline 1.112B
AstraZeneca -6.302B

NVS Cash from Investing (TTM) Range, Past 5 Years

Minimum -19.36B Sep 2010
Maximum 465.00M Jun 2014
Average -6.98B

NVS Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("NVS", "cash_investing_ttm")
  • Last 5 data points: =YCS("NVS", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.